Komarov Sergey Sergeevich

Graduated from the Ivan Fedorov Moscow State University of Printing Arts with a degree in Economics and Enterprise Management in 2011.

He began his career at Teva, providing analytical support to the Rx-Drugs business unit. In 2015, he moved to Akrikhin, where he was responsible for the formation of a portfolio of drugs under the company's brand, as well as for planning and pricing.

In 2018, he joined Sintez as a Lead Analyst of the Planning and Business Analysis Department, and later was appointed Director of Planning and Business Analysis.

In 2020, he took the position of Director for Planning and Business Analysis at Binnopharm Group.